Internal Medicine, Infectious Disease · Tyler, TX
NPI
1972503209
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
935 S Baxter Ave, Ste 103
Tyler, TX, 75701
Phone (903) 592-4473
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
2,193 services
Medicare patients, 2024
374
Average age 71
Drug cost, 2024
$2.6M
1,625 prescriptions
Company payments, 2025
$222
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard R Yates was code 99232 (hospital e&m - subsequent), 1,030 times for 282 patients. In total Richard R Yates billed 2,193 services in 15 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,030 | 282 | $60.22 | $62K |
| 99233 Hospital E&M - Subsequent | Facility | 625 | 185 | $90.50 | $57K |
| 99223 Hospital E&M - Initial | Facility | 280 | 250 | $131.12 | $37K |
| 99214 Office E&M - Established | Office | 136 | 64 | $93.02 | $13K |
| 99215 Office E&M - Established | Office | 31 | 25 | $138.32 | $4,288 |
| 99441 Telephone Services | Office | 29 | 23 | $38.92 | $1,129 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $99.53 | $1,095 |
By year: 2022 $147K for 1,901 services; 2023 $203K for 2,524 services; 2024 $179K for 2,193 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard R Yates prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 287 prescriptions and refills. In total Richard R Yates wrote 1,625 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 287 | 289 | 38 | $1.1M |
| Ceftriaxone Ceftriaxone Sodium | 135 | 135 | 29 | $9,694 |
| Cefazolin Sodium Generic | 133 | 133 | 30 | $8,046 |
| Juluca Dolutegravir/Rilpivirine | 97 | 99 | 13 | $351K |
| Daptomycin Generic | 93 | 93 | 24 | $56K |
| Cephalexin Generic | 55 | 84 | 22 | $1,444 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 53 | 57 | Under 11 | $227K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 49 | 49 | Under 11 | $197K |
| Tivicay Dolutegravir Sodium | 42 | 42 | Under 11 | $94K |
| Doxycycline Hyclate Generic | 35 | 47 | 15 | $746 |
| Cefepime Hcl Generic | 30 | 30 | Under 11 | $5,606 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 29 | 29 | Under 11 | $135K |
| Tigecycline Generic | 28 | 28 | Under 11 | $10K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 27 | 27 | Under 11 | $6,679 |
| Meropenem Generic | 25 | 25 | Under 11 | $2,730 |
Brand drugs: 708 claims; generic drugs: 917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard R Yates $222 ($222 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $190.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.